For RCC, VEGFR-TKIs Safe, Effective After PD-1 Inhibitors

Vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) are safe and effective after treatment with a programmed cell death 1 (PD-1) inhibitor in patients with metastatic renal cell carcinoma...04/09/2016
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news